Clinical Trials Related to Pediatrics
Pediatrics is the branch of medicine that involves the medical care of infants, children, and adolescents. Congenital defects, genetic variance, and developmental issues are of greater concern to pediatricians than they often are to adult physicians. A common adage is that children are not simply “little adults”. The clinician must take into account the immature physiology of the infant or child when considering symptoms, prescribing medications, and diagnosing illnesses.
Participate in a clinical trial to help find alternative treatment options for pediatric conditions.
Any illness caused by N. meningitidis can be described as meningococcal disease. Meningococcus also can infect the lungs, heart tissue, or genitourinary organs.
Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder.
Type 1 diabetes is the most common type in children, accounting for two thirds of new cases in children of all ethnic groups. It is one of the most common chronic childhood diseases, occurring in 1 in 350 children by age 18; the incidence has recently been increasing, particularly in children under 5 years. Although type 1 can occur at any age, it typically manifests between age 4 years and 6 years or between 10 years and 14 years. Type 2 diabetes, once rare in children, has been increasing in frequency in parallel with the increase in childhood obesity. It typically manifests after puberty with the highest rate between age 15 years and 19 years.
Pediatric Eczema is a skin disorder that usually appears in babies or very young children, and may last until the child reaches adolescence or adulthood. Eczema causes the skin to itch, turn red, and flake. Different triggers can make eczema worse, including environmental stress, allergies, and sweating. Of the children with eczema, 65 percent will show symptoms in the first year of life and 90 percent will show signs of eczema within the first 5 years.
Pneumococcal (pneumonia) Vaccine
Pneumococcal vaccination is a method of preventing a specific type of lung infection (pneumonia) that is caused by the pneumococcus (Streptococcus pneumoniae) bacterium. This multivalent pneumococcal vaccine is given with, or separately from, 13-valent pneumococcal conjugate vaccine in healthy infants.